SlideShare a Scribd company logo
Colorectal Cancer
Disease Pathway Management:
North East Ontario Context
Amanda Hey MD CCFP FCFP
Regional Primary Care Lead
Northeast Cancer Centre, HSN
Faculty/Presenter Disclosure
Faculty: Amanda Hey, Annelind Wakegijig, Agnes
Kanawase, Roger Boyer II, Jamie White, Michael Loreto,
Kathleen Callaghan, Julie Whitten, Traci Franklin, Sherri
Baker, Silvana Spadafora, Patrick Critchley

Relationships with commercial interests:
•Grants/Research Support: none
•Speakers Bureau/Honoraria: none
•Consulting Fees: none
•Other: none
Disease Pathway Management
Disease Pathway Management

https://www.cancercare.on.ca/ocs/qpi/dispathmgmt/
Disease Pathway Management

https://www.cancercare.on.ca/ocs/qpi/dispathmgmt
Evidence Alone is Never Enough

Evidence
Context

Values

JAMA Users’ Guide to the Medical Literature
American Medical Association

Circumstance
Panel Sequence
• Panel facilitator presents case
• Panelist present their topic sequentially
• Audience Q&A at the END of each panel
Panel 1: Screening-Diagnosis
Panel 2: Treatment
Panel 3: Treatment-Survivorship-Palliative
Regional Aboriginal Cancer Lead
Will provide leadership on FNIM cancer care in the region
by:
• Engaging and collaborating with
primary care providers
• Championing the ACS II strategic
vision in collaboration with RCP staff
• Strategic planning and
program design
• Peer education and training
8
Colorectal Cancer:
A Case for Action
Annelind Wakegijig MD CCFP
Regional Aboriginal Cancer Lead
Northeast Cancer Centre, HSN
Colorectal Cancer Rates 2007

Rate per 100,000

Age Standardized Incidence and Mortality Rates
80
70
60
50
40
30
20
10
0
Male Incidence

Female
Incidence
North East

https://www.cancercare.on.ca/cms/ Accessed October 2013

Male Mortality Female Mortality
Ontario
CRC and Ontario First Nations
Colorectal cancer incidence, Ontario,
1968-2001, ages 15-74
Males

Age-standardized rate/100,000

Females
90

90

80

80

70

70

60

60

50

50

40

40

30

30

20

20

10

10

0

0

19681975

19761983

19841991

1992- 19971996 2001

Year of diagnosis
Rates age-standardized to the 1991 Canadian population
Horizontal bars around First Nations rates indicate 95%
confidence limits

19681975

19761983

19841991

19921996

19972001

Year of diagnosis
First Nations
All Ontario

Source: Surveillance & Aboriginal Cancer Care Units, CCO (2007)
Mr. TW: Case History 1
56 yr. First Nation male
• Mother was diagnosed with CRC age 66
• He was at Residential School as a child
• He seeks advice from his social worker
• He attends his community health centre
• His nurse practitioner assess him at
increased risk for CRC
• He is referred for colonoscopy

More Related Content

What's hot

What's hot (20)

Palliative Patient Journeys—providing services in a regional and rural setting
Palliative Patient Journeys—providing services in a regional and rural settingPalliative Patient Journeys—providing services in a regional and rural setting
Palliative Patient Journeys—providing services in a regional and rural setting
 
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...
 
Do we need a new system to price oncology pharmaceuticals?
Do we need a new system to price oncology pharmaceuticals?Do we need a new system to price oncology pharmaceuticals?
Do we need a new system to price oncology pharmaceuticals?
 
Engaging multidisciplinary teams in translational research and quality improv...
Engaging multidisciplinary teams in translational research and quality improv...Engaging multidisciplinary teams in translational research and quality improv...
Engaging multidisciplinary teams in translational research and quality improv...
 
An integrated model of psychosocial cancer care: a work in progress…
An integrated model of psychosocial cancer care: a work in progress…An integrated model of psychosocial cancer care: a work in progress…
An integrated model of psychosocial cancer care: a work in progress…
 
The referral process as imagined versus the referral process as done: co-deve...
The referral process as imagined versus the referral process as done: co-deve...The referral process as imagined versus the referral process as done: co-deve...
The referral process as imagined versus the referral process as done: co-deve...
 
Weight loss among patients with Head and Neck Cancer at St Vincent's Hospital...
Weight loss among patients with Head and Neck Cancer at St Vincent's Hospital...Weight loss among patients with Head and Neck Cancer at St Vincent's Hospital...
Weight loss among patients with Head and Neck Cancer at St Vincent's Hospital...
 
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
Predictors of MDT review and the impact on lung cancer survival for HNELHD re...
 
One example of how Clinical Cancer Registry level data can review practice va...
One example of how Clinical Cancer Registry level data can review practice va...One example of how Clinical Cancer Registry level data can review practice va...
One example of how Clinical Cancer Registry level data can review practice va...
 
The experience of survival following Blood and Marrow Transplant in NSW, Aust...
The experience of survival following Blood and Marrow Transplant in NSW, Aust...The experience of survival following Blood and Marrow Transplant in NSW, Aust...
The experience of survival following Blood and Marrow Transplant in NSW, Aust...
 
Less Pain, More Gain: Palliative Care for Ovarian Cancer
Less Pain, More Gain: Palliative Care for Ovarian CancerLess Pain, More Gain: Palliative Care for Ovarian Cancer
Less Pain, More Gain: Palliative Care for Ovarian Cancer
 
Pathways to smoking care for cancer patients (P-SCIP): Stage 1
Pathways to smoking care for cancer patients (P-SCIP): Stage 1Pathways to smoking care for cancer patients (P-SCIP): Stage 1
Pathways to smoking care for cancer patients (P-SCIP): Stage 1
 
PROactive evaluation of function to Avoid CardioToxicity
PROactive evaluation of function to Avoid CardioToxicityPROactive evaluation of function to Avoid CardioToxicity
PROactive evaluation of function to Avoid CardioToxicity
 
Understanding and Predicting Breast Cancer Events After Treatment
Understanding and Predicting Breast Cancer Events After TreatmentUnderstanding and Predicting Breast Cancer Events After Treatment
Understanding and Predicting Breast Cancer Events After Treatment
 
Mapping lung cancer diagnostic pathways: a qualitative study of interviews wi...
Mapping lung cancer diagnostic pathways: a qualitative study of interviews wi...Mapping lung cancer diagnostic pathways: a qualitative study of interviews wi...
Mapping lung cancer diagnostic pathways: a qualitative study of interviews wi...
 
Drug Approval & Reimbursement Processes
Drug Approval & Reimbursement ProcessesDrug Approval & Reimbursement Processes
Drug Approval & Reimbursement Processes
 
CardiovaScUlar toxicity in cancer and improvement In recovery
CardiovaScUlar toxicity in cancer and improvement In recoveryCardiovaScUlar toxicity in cancer and improvement In recovery
CardiovaScUlar toxicity in cancer and improvement In recovery
 
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
Secondary Cancers, Health Behaviour and Cancer Screening Adherence in survivo...
 
Providing coordinated cancer care: a population-based survey of patients' exp...
Providing coordinated cancer care: a population-based survey of patients' exp...Providing coordinated cancer care: a population-based survey of patients' exp...
Providing coordinated cancer care: a population-based survey of patients' exp...
 
Prostate Cancer Quality Of Care
Prostate Cancer Quality Of CareProstate Cancer Quality Of Care
Prostate Cancer Quality Of Care
 

Viewers also liked

Introduction cancer genetics and genomics
Introduction cancer genetics and genomicsIntroduction cancer genetics and genomics
Introduction cancer genetics and genomics
Nuria Lopez-Bigas
 

Viewers also liked (11)

Panel 1: Enhancing Access for Colorectal Cancer Screening and Diagnosis, Ms. ...
Panel 1: Enhancing Access for Colorectal Cancer Screening and Diagnosis, Ms. ...Panel 1: Enhancing Access for Colorectal Cancer Screening and Diagnosis, Ms. ...
Panel 1: Enhancing Access for Colorectal Cancer Screening and Diagnosis, Ms. ...
 
Genetics and Genomics in Cancer 2013: How Genomics is Changing Cancer Care, D...
Genetics and Genomics in Cancer 2013: How Genomics is Changing Cancer Care, D...Genetics and Genomics in Cancer 2013: How Genomics is Changing Cancer Care, D...
Genetics and Genomics in Cancer 2013: How Genomics is Changing Cancer Care, D...
 
Developing a localised lung cancer referral and diagnostic pathway in a regio...
Developing a localised lung cancer referral and diagnostic pathway in a regio...Developing a localised lung cancer referral and diagnostic pathway in a regio...
Developing a localised lung cancer referral and diagnostic pathway in a regio...
 
Cancer - Molecular basis
Cancer - Molecular basisCancer - Molecular basis
Cancer - Molecular basis
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of Cancer
 
An Overview of Cancer Genetics
An Overview of Cancer GeneticsAn Overview of Cancer Genetics
An Overview of Cancer Genetics
 
The Genetics of Cancer
The Genetics of CancerThe Genetics of Cancer
The Genetics of Cancer
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
Molecular Genetics and Cancer Biology
Molecular Genetics and Cancer BiologyMolecular Genetics and Cancer Biology
Molecular Genetics and Cancer Biology
 
Breast Cancer - Molecular Basis of HER2+ Disease
Breast Cancer - Molecular Basis of HER2+ DiseaseBreast Cancer - Molecular Basis of HER2+ Disease
Breast Cancer - Molecular Basis of HER2+ Disease
 
Introduction cancer genetics and genomics
Introduction cancer genetics and genomicsIntroduction cancer genetics and genomics
Introduction cancer genetics and genomics
 

Similar to Colorectal Cancer Disease Pathway Management, Northeast Ontario Context, Dr. Amanda Hey

Pancreatic-Effective-Practices-in-Pancreatic-Cancer-Programs
Pancreatic-Effective-Practices-in-Pancreatic-Cancer-ProgramsPancreatic-Effective-Practices-in-Pancreatic-Cancer-Programs
Pancreatic-Effective-Practices-in-Pancreatic-Cancer-Programs
Brissan Guardado
 
Survivorship Care and Care Plans: Transforming Challenges into Opportunities
Survivorship Care and Care Plans: Transforming Challenges into OpportunitiesSurvivorship Care and Care Plans: Transforming Challenges into Opportunities
Survivorship Care and Care Plans: Transforming Challenges into Opportunities
Carevive
 
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-ProgramsRCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
Brissan Guardado
 

Similar to Colorectal Cancer Disease Pathway Management, Northeast Ontario Context, Dr. Amanda Hey (20)

Pancreatic-Effective-Practices-in-Pancreatic-Cancer-Programs
Pancreatic-Effective-Practices-in-Pancreatic-Cancer-ProgramsPancreatic-Effective-Practices-in-Pancreatic-Cancer-Programs
Pancreatic-Effective-Practices-in-Pancreatic-Cancer-Programs
 
Survivorship Care Plans in the U.S.: Current Status and Future Challenges
Survivorship Care Plans in the U.S.: Current Status and Future ChallengesSurvivorship Care Plans in the U.S.: Current Status and Future Challenges
Survivorship Care Plans in the U.S.: Current Status and Future Challenges
 
CRF_Guideline
CRF_GuidelineCRF_Guideline
CRF_Guideline
 
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...
 
Coleman Supportive Oncology Collaborative Symposium
Coleman Supportive Oncology Collaborative SymposiumColeman Supportive Oncology Collaborative Symposium
Coleman Supportive Oncology Collaborative Symposium
 
Liza Bernstein #AACR17 Poster- Social Media Is Real Life
Liza Bernstein #AACR17 Poster- Social Media Is Real LifeLiza Bernstein #AACR17 Poster- Social Media Is Real Life
Liza Bernstein #AACR17 Poster- Social Media Is Real Life
 
FDA 2013 Clinical Investigator Training Course: A Patient Advocate’s Perspect...
FDA 2013 Clinical Investigator Training Course: A Patient Advocate’s Perspect...FDA 2013 Clinical Investigator Training Course: A Patient Advocate’s Perspect...
FDA 2013 Clinical Investigator Training Course: A Patient Advocate’s Perspect...
 
How to Be Your Best Advocate
How to Be Your Best AdvocateHow to Be Your Best Advocate
How to Be Your Best Advocate
 
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
Scripps 35th Annual Conference: Clinical Hematology & Oncology Brochure 2015
 
What Outcomes Matter in Cancer? A Literature Review
What Outcomes Matter in Cancer? A Literature ReviewWhat Outcomes Matter in Cancer? A Literature Review
What Outcomes Matter in Cancer? A Literature Review
 
Late Effects of Childhood Cancer Treatments.
Late Effects of Childhood Cancer Treatments.Late Effects of Childhood Cancer Treatments.
Late Effects of Childhood Cancer Treatments.
 
75th Anniversary & FY2019 Year-End Celebration Highlights Presentation
75th Anniversary & FY2019 Year-End Celebration Highlights Presentation75th Anniversary & FY2019 Year-End Celebration Highlights Presentation
75th Anniversary & FY2019 Year-End Celebration Highlights Presentation
 
Survivorship Care and Care Plans: Transforming Challenges into Opportunities
Survivorship Care and Care Plans: Transforming Challenges into OpportunitiesSurvivorship Care and Care Plans: Transforming Challenges into Opportunities
Survivorship Care and Care Plans: Transforming Challenges into Opportunities
 
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershman
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. HershmanSHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershman
SHARE Webinar: Why Should I Join a Clinical Trial with Dr. Hershman
 
HANDOUT - Hospice & Palliative Care Missouri Health Net Aug 2009
HANDOUT - Hospice & Palliative Care Missouri Health Net Aug 2009HANDOUT - Hospice & Palliative Care Missouri Health Net Aug 2009
HANDOUT - Hospice & Palliative Care Missouri Health Net Aug 2009
 
Setting Up for Survivorship Success
Setting Up for Survivorship SuccessSetting Up for Survivorship Success
Setting Up for Survivorship Success
 
CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?
 
Problems and perspectives of development of psycho-oncology in Georgia and in...
Problems and perspectives of development of psycho-oncology in Georgia and in...Problems and perspectives of development of psycho-oncology in Georgia and in...
Problems and perspectives of development of psycho-oncology in Georgia and in...
 
Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...
 
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-ProgramsRCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
RCC-Effective-Practices-in-Renal-Cell-Carcinoma-Programs
 

More from Health Sciences North | Horizon Santé Nord

More from Health Sciences North | Horizon Santé Nord (12)

Questions to Ask Your Care Provider - Patient Safety
Questions to Ask Your Care Provider - Patient SafetyQuestions to Ask Your Care Provider - Patient Safety
Questions to Ask Your Care Provider - Patient Safety
 
Alcohol Use Among Post Secondary Students
Alcohol Use Among Post Secondary StudentsAlcohol Use Among Post Secondary Students
Alcohol Use Among Post Secondary Students
 
End of Life Public Forum 2 - Dr. Andrew Knight - Feb. 6, 2014
End of Life Public Forum 2 - Dr. Andrew Knight - Feb. 6, 2014End of Life Public Forum 2 - Dr. Andrew Knight - Feb. 6, 2014
End of Life Public Forum 2 - Dr. Andrew Knight - Feb. 6, 2014
 
End of Life Public Forum 2 - Sr. Costanza Romano - Feb.6, 2014
End of Life Public Forum 2 - Sr. Costanza Romano - Feb.6, 2014End of Life Public Forum 2 - Sr. Costanza Romano - Feb.6, 2014
End of Life Public Forum 2 - Sr. Costanza Romano - Feb.6, 2014
 
End of Life Public Forum 2 - Lise Poratto Mason - Feb.6, 2014
End of Life Public Forum 2 - Lise Poratto Mason - Feb.6, 2014End of Life Public Forum 2 - Lise Poratto Mason - Feb.6, 2014
End of Life Public Forum 2 - Lise Poratto Mason - Feb.6, 2014
 
End of Life Public Forum 2 - Frankie Vitone - Feb. 6, 2014
End of Life Public Forum 2 - Frankie Vitone - Feb. 6, 2014End of Life Public Forum 2 - Frankie Vitone - Feb. 6, 2014
End of Life Public Forum 2 - Frankie Vitone - Feb. 6, 2014
 
End of Life From My Side of The Gurney | Dr. Brian Goldman
End of Life From My Side of The Gurney | Dr. Brian Goldman End of Life From My Side of The Gurney | Dr. Brian Goldman
End of Life From My Side of The Gurney | Dr. Brian Goldman
 
Dying, Dignity and Palliative End-of-Life Care | Dr. Harvey Chochinov
Dying, Dignity and Palliative End-of-Life Care | Dr. Harvey ChochinovDying, Dignity and Palliative End-of-Life Care | Dr. Harvey Chochinov
Dying, Dignity and Palliative End-of-Life Care | Dr. Harvey Chochinov
 
2013 Regional Oncology Conference: Closing Remarks, Mr. Mark Hartman
2013 Regional Oncology Conference: Closing Remarks, Mr. Mark Hartman2013 Regional Oncology Conference: Closing Remarks, Mr. Mark Hartman
2013 Regional Oncology Conference: Closing Remarks, Mr. Mark Hartman
 
Panel 2: Optimizing Integrated Colorectal Cancer Treatment Planning and Patie...
Panel 2: Optimizing Integrated Colorectal Cancer Treatment Planning and Patie...Panel 2: Optimizing Integrated Colorectal Cancer Treatment Planning and Patie...
Panel 2: Optimizing Integrated Colorectal Cancer Treatment Planning and Patie...
 
Designing a More Seniors-friendly Health Care System
Designing a More Seniors-friendly Health Care SystemDesigning a More Seniors-friendly Health Care System
Designing a More Seniors-friendly Health Care System
 
Community Notice: Temporary Helipad
Community Notice: Temporary Helipad Community Notice: Temporary Helipad
Community Notice: Temporary Helipad
 

Recently uploaded

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 

Colorectal Cancer Disease Pathway Management, Northeast Ontario Context, Dr. Amanda Hey

  • 1. Colorectal Cancer Disease Pathway Management: North East Ontario Context Amanda Hey MD CCFP FCFP Regional Primary Care Lead Northeast Cancer Centre, HSN
  • 2. Faculty/Presenter Disclosure Faculty: Amanda Hey, Annelind Wakegijig, Agnes Kanawase, Roger Boyer II, Jamie White, Michael Loreto, Kathleen Callaghan, Julie Whitten, Traci Franklin, Sherri Baker, Silvana Spadafora, Patrick Critchley Relationships with commercial interests: •Grants/Research Support: none •Speakers Bureau/Honoraria: none •Consulting Fees: none •Other: none
  • 6. Evidence Alone is Never Enough Evidence Context Values JAMA Users’ Guide to the Medical Literature American Medical Association Circumstance
  • 7. Panel Sequence • Panel facilitator presents case • Panelist present their topic sequentially • Audience Q&A at the END of each panel Panel 1: Screening-Diagnosis Panel 2: Treatment Panel 3: Treatment-Survivorship-Palliative
  • 8. Regional Aboriginal Cancer Lead Will provide leadership on FNIM cancer care in the region by: • Engaging and collaborating with primary care providers • Championing the ACS II strategic vision in collaboration with RCP staff • Strategic planning and program design • Peer education and training 8
  • 9. Colorectal Cancer: A Case for Action Annelind Wakegijig MD CCFP Regional Aboriginal Cancer Lead Northeast Cancer Centre, HSN
  • 10. Colorectal Cancer Rates 2007 Rate per 100,000 Age Standardized Incidence and Mortality Rates 80 70 60 50 40 30 20 10 0 Male Incidence Female Incidence North East https://www.cancercare.on.ca/cms/ Accessed October 2013 Male Mortality Female Mortality Ontario
  • 11. CRC and Ontario First Nations Colorectal cancer incidence, Ontario, 1968-2001, ages 15-74 Males Age-standardized rate/100,000 Females 90 90 80 80 70 70 60 60 50 50 40 40 30 30 20 20 10 10 0 0 19681975 19761983 19841991 1992- 19971996 2001 Year of diagnosis Rates age-standardized to the 1991 Canadian population Horizontal bars around First Nations rates indicate 95% confidence limits 19681975 19761983 19841991 19921996 19972001 Year of diagnosis First Nations All Ontario Source: Surveillance & Aboriginal Cancer Care Units, CCO (2007)
  • 12. Mr. TW: Case History 1 56 yr. First Nation male • Mother was diagnosed with CRC age 66 • He was at Residential School as a child • He seeks advice from his social worker • He attends his community health centre • His nurse practitioner assess him at increased risk for CRC • He is referred for colonoscopy